DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
-2.61%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$43.4B
AUM Growth
-$1.09B
(-2.4%)
Cap. Flow
+$59.4M
Cap. Flow
% of AUM
0.14%
Top 10 Holdings %
Top 10 Hldgs %
24.12%
Holding
1,560
New
305
Increased
525
Reduced
442
Closed
68
Top Buys
| 1 |
CRH
CRH
|
+$217M |
| 2 |
Meta Platforms (Facebook)
META
|
+$199M |
| 3 |
Exelon
EXC
|
+$99.8M |
| 4 |
MetLife
MET
|
+$89.1M |
| 5 |
Eli Lilly
LLY
|
+$70.3M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$150M |
| 2 |
Amgen
AMGN
|
+$96.4M |
| 3 |
Applied Materials
AMAT
|
+$73.6M |
| 4 |
Parker-Hannifin
PH
|
+$69.4M |
| 5 |
Microsoft
MSFT
|
+$66.7M |
Sector Composition
| 1 | Technology | 27.32% |
| 2 | Healthcare | 17.93% |
| 3 | Financials | 10.39% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Industrials | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Crocs
CROX
$4.43B
| $335K | ﹤0.01% |
3,875
+2,616
| +208% | +$226K |
|
1102
Crinetics Pharmaceuticals
CRNX
$3.3B
| $333K | ﹤0.01% |
11,300
| – | – |
|
1103
SentinelOne
S
$5.98B
| $327K | ﹤0.01% |
20,000
| – | – |
|
1104
Itron
ITRI
$5.41B
| $326K | ﹤0.01% |
5,450
| – | – |
|
1105
Radware
RDWR
$1.1B
| $324K | ﹤0.01% |
19,500
| – | – |
|
1106
Novavax
NVAX
$1.29B
| $322K | ﹤0.01% |
+45,000
| New | +$322K |
|
1107
Chewy
CHWY
$14.6B
| $321K | ﹤0.01% |
17,709
+3,559
| +25% | +$64.5K |
|
|
VRNA
1108
Verona Pharma
VRNA
$9.2B
| $320K | ﹤0.01% |
20,000
| – | – |
|
1109
Ormat Technologies
ORA
$5.51B
| $319K | ﹤0.01% |
4,607
-2,239
| -33% | -$155K |
|
|
SVC
1110
Service Properties Trust
SVC
$469M
| $319K | ﹤0.01% |
41,363
| – | – |
|
|
PDCO
1111
DELISTED
Patterson Companies, Inc.
PDCO
| $319K | ﹤0.01% |
+10,757
| New | +$319K |
|
1112
SPS Commerce
SPSC
$4.18B
| $318K | ﹤0.01% |
+1,855
| New | +$318K |
|
1113
Winnebago Industries
WGO
$953M
| $317K | ﹤0.01% |
5,258
-1,195
| -19% | -$72K |
|
|
GMS
1114
DELISTED
GMS Inc
GMS
| $316K | ﹤0.01% |
+4,926
| New | +$316K |
|
|
GTY
1115
Getty Realty Corp
GTY
$1.6B
| $316K | ﹤0.01% |
11,655
| – | – |
|
|
VRE
1116
Veris Residential
VRE
$1.49B
| $316K | ﹤0.01% |
19,384
| – | – |
|
1117
Coca-Cola Consolidated
COKE
$10.5B
| $315K | ﹤0.01% |
+4,880
| New | +$315K |
|
1118
Flowserve
FLS
$7.35B
| $315K | ﹤0.01% |
8,000
| – | – |
|
1119
Kymera Therapeutics
KYMR
$3.11B
| $315K | ﹤0.01% |
22,000
| – | – |
|
1120
Ocular Therapeutix
OCUL
$2.27B
| $313K | ﹤0.01% |
100,000
| – | – |
|
1121
89bio
ETNB
$1.26B
| $309K | ﹤0.01% |
20,000
| – | – |
|
1122
ImmunityBio
IBRX
$2.43B
| $309K | ﹤0.01% |
196,200
| – | – |
|
1123
Shinhan Financial Group
SHG
$23.7B
| $307K | ﹤0.01% |
11,779
| – | – |
|
1124
CNO Financial Group
CNO
$3.8B
| $303K | ﹤0.01% |
12,645
+202
| +2% | +$4.84K |
|
|
ALEX
1125
Alexander & Baldwin
ALEX
$1.36B
| $302K | ﹤0.01% |
18,263
| – | – |
|